Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece Department of Primary Education, University of Ioannina, Ioannina, Greece.
Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.
Evid Based Ment Health. 2014 Aug;17(3):85-9. doi: 10.1136/eb-2014-101900. Epub 2014 Jul 9.
Missing outcome data are a common problem in clinical trials and systematic reviews, as it compromises inferences by reducing precision and potentially biasing the results. Systematic reviewers often assume that the missing outcome problem has been resolved at the trial level. However, in many clinical trials a complete case analysis or suboptimal imputation techniques are employed and the problem is accumulated in a quantitative synthesis of trials via meta-analysis. The risk of bias due to missing data depends on the missingness mechanism. Most statistical analyses assume missing data to be missing at random, which is an unverifiable assumption. The aim of this paper is to present methods used to account for missing outcome data in a systematic review and meta-analysis.
The following methods to handle missing outcome data are presented: (1) complete cases analysis, (2) imputation methods from observed data, (3) best/worst case scenarios, (4) uncertainty interval for the summary estimate and (5) a statistical model that makes assumption about how treatment effects in missing data are connected to those in observed data. Examples are used to illustrate all the methods presented.
Different methods yield different results. A complete case analysis leads to imprecise and potentially biased results. The best-case/worst-case scenarios give unrealistic estimates, while the uncertainty interval produces very conservative results. Imputation methods that replace missing data with values from the observed data do not properly account for the uncertainty introduced by the unobserved data and tend to underestimate SEs. Employing a statistical model that links treatment effects in missing and observed data, unlike the other methods, reduces the weight assigned to studies with large missing rates.
Unlike clinical trials, in systematic reviews and meta-analyses we cannot adapt pre-emptive methods to account for missing outcome data. There are statistical techniques implemented in commercial software (eg, STATA) that quantify the departure from the missing at random assumption and adjust results appropriately. A sensitivity analysis with increasingly stringent assumptions on how parameters in the unobserved and observed data are related is a sensible way to evaluate robustness of results.
在临床试验和系统评价中,缺失结局数据是一个常见问题,因为这会降低精度并潜在地影响结果的偏倚,从而影响推论。系统评价者通常假设试验层面已经解决了缺失结局问题。然而,在许多临床试验中,采用了完全病例分析或次优的推断技术,并且通过荟萃分析在试验的定量综合中积累了问题。缺失数据引起的偏倚风险取决于缺失机制。大多数统计分析假设缺失数据是随机缺失的,这是一个未经证实的假设。本文的目的是介绍系统评价和荟萃分析中处理缺失结局数据的方法。
介绍了以下处理缺失结局数据的方法:(1)完全病例分析,(2)基于观察数据的推断方法,(3)最佳/最差情况设想,(4)汇总估计的不确定区间,以及(5)一个关于缺失数据中治疗效果与观察数据中治疗效果之间关系的统计模型。使用示例来说明所有呈现的方法。
不同的方法会产生不同的结果。完全病例分析会导致不精确和潜在有偏倚的结果。最佳/最差情况设想给出不现实的估计,而不确定区间则产生非常保守的结果。用来自观察数据的值替换缺失数据的推断方法并不能正确考虑未观察数据引入的不确定性,并且往往会低估标准误。与其他方法不同,采用将缺失和观察数据中的治疗效果联系起来的统计模型,可以减少对缺失率较大的研究的权重分配。
与临床试验不同,在系统评价和荟萃分析中,我们不能采用预先的方法来处理缺失结局数据。商业软件(如 STATA)中实施了一些统计技术,可以量化偏离随机缺失假设的程度,并适当调整结果。对未观察和观察数据中参数之间的关系进行越来越严格的假设敏感性分析是评估结果稳健性的合理方法。